Jynarque
Ended Awarded
- Contract number
- 36C26124N0418
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $125,849
Award facts
- Contract value 100% obligated
- $125,848.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. received a $125,848.80 firm fixed-price delivery order from the Department of Veterans Affairs (VA), specifically from Veterans Integrated Service Network 21, for Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. The delivery order, awarded on February 2, 2024, with completion targeted for September 30, 2024, will be performed in Potomac, Maryland. This award does not utilize a set-aside designation and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
This delivery order is issued against Otsuka America Pharmaceutical Inc.'s larger Indefinite Delivery Vehicle—an $83.3 million Blanket Purchase Agreement for Jynarque with the VA's National Acquisition Center that extends through March 26, 2026. The BPA enables multiple VA Integrated Service Networks to efficiently procure this critical pharmaceutical treatment for veterans nationwide. As a major pharmaceutical supplier to the VA, Otsuka America maintains significant federal contracting relationships, including a $396 million Federal Supply Schedule contract for pharmaceuticals and related products, positioning the company as an established provider of specialized medications to federal healthcare systems.
Quick answers
Who was awarded contract 36C26124N0418?
36C26124N0418 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on February 2, 2024.
How much is contract 36C26124N0418 worth?
The government has obligated $125,849 on 36C26124N0418.
Is contract 36C26124N0418 an order under another contract?
Yes. 36C26124N0418 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0418 competed?
The extent of competition for 36C26124N0418 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award